CINCINNATI ( Cincinnati Business Courier) - A growing biotech and pharmaceuticals manufacturer that announced a large ...

Rosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights Rosen Law Firm, a global investor rights law firm ...

NEW YORK, March 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA). Shareholders who purchased shares of SANA ...

A rate drop, according to analysts, may release billions of dollars in investment funds that have been put aside for fledgling biotech firms looking for steady funding. Investor interest in ...

A Cambridge-based biotechnology firm developing antibody-based KnotBody drugs for ion channel- and G protein-coupled receptor (GPCR)-driven diseases, has raised £58m in a Series A financing. Maxion is ...

Oman’s sovereign wealth fund, the Oman Investment Authority (OIA), has invested in Tidal Vision, an American biotech firm specialising in biopolymers. The sultanate’s investment arm, whose assets ...

A biotech firm which received €4.7 million in support from the European Union's Just Transition Fund has announced that it will forgo that support. Biotech startup ÄIO had planned to build a showcase ...

NASDAQ-listed biopharmaceutical firm Atai Life Sciences says cryptocurrencies like Bitcoin could be key to survival for biotech startups as they wade through years of regulatory approvals.

bluebird bio Inc. (NASDAQ:BLUE), a biotechnology company with a market capitalization of approximately $40 million, focuses on developing treatments for severe genetic diseases and cancer.

A rate drop, according to analysts, may release billions of dollars in investment funds that have been put aside for fledgling biotech firms looking for steady funding. Investor interest in ...